EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Quality of Artemether-Lumefantrine-based Antimalarials from the Illicit Ivorian Market in West Africa

Déto N'guessan, Songuigama Coulibaly, Alain Kacou, Avi Kouao, Amelanh Diakité, Jean-Fabrice Koffi, Melissa Adouko, Mahama Ouattara

International Journal of Pharmacy and Chemistry · 24.01.2025 · 11 (1) · 22-30

DOI: 10.11648/j.ijpc.20251101.14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmacy and Chemistry, online erschienen am 24.01.2025. Verfasst von Déto N'guessan und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Counterfeit and substandard medicines represent a severe public health issue, particularly in developing nations where their prevalence exacerbates disease resistance and economic challenges. In addition, many deaths in Côte d'Ivoire could be avoided each year if the drugs prescribed against malaria were compliant with regulations and able to effectively treat the disease.

Objective

This study aimed to evaluate the quality of artemether-lumefantrine antimalarial combination on the Ivorian illicit market using the GPHF-Minilab® kit.

Methods

A total of 15 samples were analyzed through visual inspection, disintegration testing, and TLC for qualitative and semi-quantitative assessments.

Results

The findings reveal significant non-conformities, including 20% of samples lacking manufacturer information, 7% without accompanying instructions, and 20% with physical degradation. 93% of samples disintegrated within 30 minutes, meeting pharmacopoeial standards. One sample exceeded the recommended time, indicating substandard manufacturing. Most samples (67%) met active ingredient quantity requirements, but 26% were underdosed, and 7% were overdosed, highlighting manufacturing and storage deficiencies. In view of these results, it appears that the Artemether-lumefantrine drugs seized on the illegal market in Côte d'Ivoire are not of good quality.

Conclusion

The GPHF-Minilab® proves a reliable tool for identifying substandard and counterfeit drugs in resource-limited settings, though further validation is required for broader applications. These results underscore the need for stringent regulatory frameworks, public education, and expanded quality control initiatives.

Zitieren

APA

N'guessan, D., Coulibaly, S., Kacou, A., Kouao, A., Diakité, A., Koffi, J., Adouko, M., & Ouattara, M. (2025). Evaluation of the Quality of Artemether-Lumefantrine-based Antimalarials from the Illicit Ivorian Market in West Africa. International Journal of Pharmacy and Chemistry, 11(1), 22-30. https://doi.org/10.11648/j.ijpc.20251101.14

Vancouver

N'guessan D, Coulibaly S, Kacou A, Kouao A, Diakité A, Koffi J, et al. Evaluation of the Quality of Artemether-Lumefantrine-based Antimalarials from the Illicit Ivorian Market in West Africa. International Journal of Pharmacy and Chemistry. 2025;11(1):22-30. doi:10.11648/j.ijpc.20251101.14

BibTeX
@article{Nguessan2025,
  author = {N'guessan, Déto and Coulibaly, Songuigama and Kacou, Alain and Kouao, Avi and Diakité, Amelanh and Koffi, Jean-Fabrice and Adouko, Melissa and Ouattara, Mahama},
  title = {Evaluation of the Quality of Artemether-Lumefantrine-based Antimalarials from the Illicit Ivorian Market in West Africa},
  journal = {International Journal of Pharmacy and Chemistry},
  year = {2025},
  volume = {11},
  number = {1},
  pages = {22--30},
  doi = {10.11648/j.ijpc.20251101.14}
}
Kostenlos starten →